Contineum Therapeutics
CTNM
#6725
Rank
NZ$0.79 B
Marketcap
$30.81
Share price
-0.81%
Change (1 day)
N/A
Change (1 year)

Revenue for Contineum Therapeutics (CTNM)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of NZ$79.06 Million.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Contineum Therapeutics from 2023 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A-100%
2023 NZ$79.06 M